Small Trial Finds GLP-1 Lowers Heavy Drinking Days in Individuals with Alcohol Use Disorder and Obesity
In a groundbreaking clinical trial, investigators have demonstrated that once-weekly semaglutide injections can dramatically reduce heavy drinking days among adults ...
